These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28006926)

  • 1. Athymic nude mice as an experimental model for cancer treatment.
    Szadvari I; Krizanova O; Babula P
    Physiol Res; 2016 Dec; 65(Suppl 4):S441-S453. PubMed ID: 28006926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review.
    Jin K; Teng L; Shen Y; He K; Xu Z; Li G
    Clin Transl Oncol; 2010 Jul; 12(7):473-80. PubMed ID: 20615824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.
    Kelland LR
    Eur J Cancer; 2004 Apr; 40(6):827-36. PubMed ID: 15120038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing PARP Inhibitors Using a Murine Xenograft Model.
    Makhov P; Naito S; Kolenko VM
    Methods Mol Biol; 2017; 1608():313-320. PubMed ID: 28695518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of human colon tumor growth by adenoviral vector-mediated NK4 expression in an athymic mouse model.
    Jie JZ; Wang JW; Qu JG; Hung T
    World J Gastroenterol; 2007 Apr; 13(13):1938-46. PubMed ID: 17461494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peginterferon Beta-1a Shows Antitumor Activity as a Single Agent and Enhances Efficacy of Standard of Care Cancer Therapeutics in Human Melanoma, Breast, Renal, and Colon Xenograft Models.
    Boccia A; Virata C; Lindner D; English N; Pathan N; Brickelmaier M; Hu X; Gardner JL; Peng L; Wang X; Zhang X; Yang L; Perron K; Yco G; Kelly R; Gamez J; Scripps T; Bennett D; Joseph IB; Baker DP
    J Interferon Cytokine Res; 2017 Jan; 37(1):20-31. PubMed ID: 27835061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunobiological aspects of the nude mouse model relative to human cancer chemosensitivity tests.
    Rivosecchi Merletti P; Bianchi R; Nardelli B; Iorio AM; Campanile F; Migliorati G; Bonmassar E
    Int J Tissue React; 1983; 5(1):19-27. PubMed ID: 6862787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEN4901/T-0128, a new camptothecin derivative-carboxymethyldextran conjugate, has potent antitumor activities in a panel of human tumor xenografts in nude mice.
    Fujita F; Koike M; Fujita M; Sakamoto Y; Okuno S; Kawaguchi T; Yano S; Yano T; Kiuchi S; Fujiwara T; Kudoh S; Kakushima M
    Clin Cancer Res; 2005 Feb; 11(4):1650-7. PubMed ID: 15746070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor activity of mycophenolate mofetil against human and mouse tumors in vivo.
    Tressler RJ; Garvin LJ; Slate DL
    Int J Cancer; 1994 May; 57(4):568-73. PubMed ID: 8181860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical chemotherapy on human head and neck cancer xenografts grown in athymic nude mice.
    Braakhuis BJ; van Dongen GA; Bagnay M; van Walsum M; Snow GB
    Head Neck; 1989; 11(6):511-5. PubMed ID: 2584006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Pharmacology Models for Cancer Target Research.
    Chen D; An X; Ouyang X; Cai J; Zhou D; Li QX
    Methods Mol Biol; 2019; 1953():183-211. PubMed ID: 30912023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NHS76/PEP2, a fully human vasopermeability-enhancing agent to increase the uptake and efficacy of cancer chemotherapy.
    Khawli LA; Hu P; Epstein AL
    Clin Cancer Res; 2005 Apr; 11(8):3084-93. PubMed ID: 15837764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual mode of action of a human anti-epidermal growth factor receptor monoclonal antibody for cancer therapy.
    Bleeker WK; Lammerts van Bueren JJ; van Ojik HH; Gerritsen AF; Pluyter M; Houtkamp M; Halk E; Goldstein J; Schuurman J; van Dijk MA; van de Winkel JG; Parren PW
    J Immunol; 2004 Oct; 173(7):4699-707. PubMed ID: 15383606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jianpi Jiedu decoction, a traditional Chinese medicine formula, inhibits tumorigenesis, metastasis, and angiogenesis through the mTOR/HIF-1α/VEGF pathway.
    Peng W; Zhang S; Zhang Z; Xu P; Mao D; Huang S; Chen B; Zhang C; Zhang S
    J Ethnopharmacol; 2018 Oct; 224():140-148. PubMed ID: 29852266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
    Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
    Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic behavior of human tumors in congenitally athymic nude mice: intrinsic properties of the tumor cells and host immune reactivity.
    Rofstad EK
    Int J Cancer; 1995 Nov; 63(5):744-9. PubMed ID: 7591295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human tumor xenografts in the nude mouse and their value as test models in anticancer drug development (review).
    Winograd B; Boven E; Lobbezoo MW; Pinedo HM
    In Vivo; 1987; 1(1):1-13. PubMed ID: 2979758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft.
    Luo FR; Yang Z; Dong H; Camuso A; McGlinchey K; Fager K; Flefleh C; Kan D; Inigo I; Castaneda S; Rose WC; Kramer RA; Wild R; Lee FY
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):455-64. PubMed ID: 15947929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of growth of HER2-positive ovarian cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate in mouse xenograft model.
    Yu L; Wang Y; Yao Y; Li W; Lai Q; Li J; Zhou Y; Kang T; Xie Y; Wu Y; Chen X; Yi C; Gou L; Yang J
    Int J Gynecol Cancer; 2014 Sep; 24(7):1158-64. PubMed ID: 24987913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.